The role of pattern recognition receptors in intestinal inflammation

Mucosal Immunology

Volumn 6, Issue 3, 2013, Pages 451-463

  Fukata, M ^a   Arditi, M ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRX 526; CRYOPYRIN; GLIBENCLAMIDE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROTEIN NLRP12; PROTEIN NLRP6; RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

CANCER PREVENTION; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENTERITIS; HUMAN; INTESTINE EPITHELIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 84876348441     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.13     Document Type: Review

References (144)

1. Thompson, M.R., Kaminski, J.J., Kurt-Jones, E.A. & Fitzgerald, K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920-940 (2011).
2. Watts, C., West, M.A. & Zaru, R. TLR signalling regulated antigen presentation in dendritic cells. Curr. Opin. Immunol. 22, 124-130 (2010).
3. Rahman, A.H., Taylor, D.K. & Turka, L.A. The contribution of direct TLR signaling to Tcell responses. Immunol. Res. 45, 25-36 (2009).
4. DeFranco, A.L., Rookhuizen, D.C. & Hou, B. Contribution of Toll-like receptor signaling to germinal center antibody responses. Immunol. Rev. 247, 64-72 (2012).
5. Otte, J.M., Cario, E. & Podolsky, D.K. Mechanisms of cross hyporespon-siveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126, 1054-1070 (2004).
6. Melmed, G. et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170, 1406-1415 (2003).
7. Smythies, L.E. et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75 (2005).
8. Gong, J. et al. Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clin. Immunol. 136, 245-256 (2010).
9. Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561 (2007).
10. Kajino-Sakamoto, R. et al. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J. Immunol. 181, 1143-1152 (2008).
11. Lee, J. et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8, 1327-1336 (2006).
12. Vaishnava, S., Behrendt, C.L, Ismail, A.S., Eckmann, L. & Hooper, L.V Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA 105, 20858-20863 (2008).
13. Sodhi, C.P. et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143, 708-718. e701-705 (2012).
14. Palazzo, M. et al. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J. Immunol. 178, 4296-4303 (2007).
15. Kobayashi, K.S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 (2005).
16. Wehkamp, J. et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53, 1658-1664 (2004).
17. Schultsz, C, Van Den Berg, F.M., Ten Kate, F.W., Tytgat, G.N. & Dankert, J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117, 1089-1097 (1999).
18. Vora, P. et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J. Immunol. 173, 5398-5405 (2004).
19. Uehara, A., Fujimoto, Y., Fukase, K. & Takada, H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 44, 3100-3111 (2007).
20. He, B. et al. Intestinal bacteriatriggerTcell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826 (2007).
21. Shang, L. et al. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135, 529-538 (2008).
22. Bruno, M.E. et al. Regulation of the polymeric immunoglobulin receptor in intestinal epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis. Immunol. Invest. 39, 356-382 (2010).
23. Schneeman, TA. et al. Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses. J. Immunol. 175, 376-384 (2005).
24. Macpherson, A.J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665 (2004).
25. Vijay-Kumar, M. et al. Deletion of TLR5 results in spontaneous colitis in mice. J. Clin. Invest. 117, 3909-3921 (2007).
26. Wang, Y. et al. Rig-I-/-mice develop colitis associated with downregulation of G alpha i2. Cell Res. 17, 858-868 (2007).
27. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
28. Fukata, M. et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm. Bowel Dis. 17, 1464-1473 (2011).
29. Asquith, M.J., Boulard, O., Powrie, F. & Maloy, K.J. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology 139, 519-529. e511-512 (2010).
30. Gibson, D.L. et al. Interleukin-11 reduces TLR4-induced colitis in TLR2-deficient mice and restores intestinal STAT3 signaling. Gastro-enterology 139, 1277-1288 (2010).
31. Tamboli, C.P., Neut, C., Desreumaux, P. & Colombel, J.F. Dysbiosis as a prerequisite for IBD. Gut 53, 1057 (2004).
32. Heimesaat, M.M. et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2, e662 (2007).
33. Ubeda, C. et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445-1456 (2012).
34. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
35. Kim, S.C. et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128, 891-906 (2005).
36. Rakoff-Nahoum, S., Hao, L. & Medzhitov, R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25, 319-329 (2006).
37. Gonzalez-Navajas, J.M. et al. TLR4 signaling in effector CD4 + T cells regulates TCR activation and experimental colitis in mice. J. Clin. Invest. 120, 570-581 (2010).
38. Biswas, A. et al. Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur. J. Immunol. 41, 182-194 (2011).
39. Matharu, K.S. et al. Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice. Gastroenterology 137, 1380-1390. e1381-1383 (2009).
40. Messlik, A. et al. Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation. J. Proteome Res. 8, 4406-4417 (2009).
41. Garrett, W.S. et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16, 208-219 (2009).
42. Powell, N. et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor + innate lymphoid cells. Immunity 37, 674-684 (2012).
43. Carvalho, F.A. et al. Interleukin-1beta (IL-1beta) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 61, 373-384 (2012).
44. Gonzalez-Navajas, J.M. et al. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. J. Exp. Med. 207, 2799-2807 (2010).
45. Zheng, L., Riehl, T.E. & Stenson, W.F. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid. Gastroenterology 137, 2041-2051 (2009).
46. Lim, D.M. & Wang, M.L. Toll-like receptor 3 signaling enables human esophageal epithelial cells to sense endogenous danger signals released by necrotic cells. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G91-G99 (2011).
47. Dieleman, L.A. et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652 (1994).
48. Kitajima, S., Morimoto, M., Sagara, E., Shimizu, C. & Ikeda, Y. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp. Anim. 50, 387-395 (2001).
49. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
50. Fukata, M. et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1055-G1065 (2005).
51. Choi, Y.J., Im, E., Chung, H.K., Pothoulakis, C. & Rhee, S.H. TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells. J. Biol. Chem. 285, 37570-37578 (2010).
52. Cario, E., Gerken, G. & Podolsky, D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374 (2007).
53. Cario, E., Gerken, G. & Podolsky, D.K. Toll-like receptor2 enhancesZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224-238 (2004).
54. Podolsky, D.K., Gerken, G., Eyking, A. & Cario, E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137, 209-220 (2009).
55. Fukata, M. et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131, 862-877 (2006).
56. Hernandez, Y. et al. The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia. BMC Gastroenterol. 10, 82 (2010).
57. Pull, S.L., Doherty, J.M., Mills, J.C., Gordon, J.I. & Stappenbeck, TS. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 102, 99-104 (2005).
58. Brown, S.L. et al. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Invest. 117, 258-269 (2007).
59. Fukata, M. et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869-1881 (2007).
60. Obermeier, F. et al. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology 129, 913-927 (2005).
61. Chen, G.Y., Liu, M., Wang, F., Bertin, J. & Nunez, G. Afunctional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187-7194 (2011).
62. Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. USA 108, 9601-9606 (2011).
63. Kempster, S.L. et al. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G253-G263 (2011).
64. Eun, C.S. et al. Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway. Dig. Dis. Sci. 51, 693-697 (2006).
65. Dubuquoy, L. et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124, 1265-1276 (2003).
66. Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477-481 (2012).
67. Garrett, W.S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45 (2007).
68. Penack, O. et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 206, 2101-2110 (2009).
69. Petnicki-Ocwieja, T. et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. USA 106, 15813-15818 (2009).
70. Yang, Z. et al. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology 133, 1510-1521 (2007).
71. Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307, 734-738 (2005).
72. Chen, G.Y, Shaw, M.H., Redondo, G. & Nunez, G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68, 10060-10067 (2008).
73. Natividad, J.M. et al. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1 (-/-);Nod2(-/-) Mice. Inflamm. Bowel Dis. 18, 1434-1446 (2011).
74. Hirota, S.A. et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm. Bowel Dis. 17, 1359-1372 (2011).
75. Zaki, M.H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010).
76. Allen, I.C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045-1056 (2010).
77. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378 (2010).
78. Siegmund, B. et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1264-R1273 (2001).
79. Sivakumar, P.V. et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812-820 (2002).
80. Ishikura, T. et al. Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice. J. Gastroenterol. Hepatol. 18, 960-969 (2003).
81. Bauer, C. et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59, 1192-1199 (2010).
82. Zaki, M.H., Lamkanfi, M. & Kanneganti, T.D. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol. 32, 171-179 (2011).
83. Nava, P. et al. Interferon-gamma regulates intestinal epithelial home-ostasis through converging beta-catenin signaling pathways. Immunity 32, 392-402 (2010).
84. Fantuzzi, G., Puren, A.J., Harding, M.W., Livingston, D.J. & Dinarello, C.A. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91, 2118-2125 (1998).
85. Zaki, M.H., Vogel, P., Body-Malapel, M., Lamkanfi, M. & Kanneganti, T.D. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185, 4912-4920 (2010).
86. Okamura, H., Kashiwamura, S., Tsutsui, H., Yoshimoto, T. & Nakanishi, K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10, 259-264 (1998).
87. Donnet-Hughes, A. et al. Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc. Nutr. Soc. 69, 407-415 (2010).
88. Diaz, R.L. et al. Maternal adaptive immunity influences the intestinal microflora of suckling mice. J. Nutr. 134, 2359-2364 (2004).
89. Atarashi, K. et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 455, 808-812 (2008).
90. Ko, M.K., Saraswathy, S., Parikh, J.G. & Rao, N.A. The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest. Ophthalmol. Vis. Sci. 52, 5824-5835 (2011).
91. Suliman, H.B. et al. Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J. 19, 1531-1533 (2005).
92. Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414 (2012).
93. Itzkowitz, S.H. Microsatellite instability in colitis associated colorectal cancer. Gut 46, 304-305 (2000).
94. Itzkowitz, S.H. & Yio, X. Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G7-17 (2004).
95. Ullman, T.A. & Itzkowitz, S.H. Intestinal inflammation and cancer. Gastroenterology 140, 1807-1816 (2011).
96. Kundu, J.K. & Surh, Y.J. Inflammation: gearing the journey to cancer. Mutat. Res. 659, 15-30 (2008).
97. Ono, M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 99, 1501-1506 (2008).
98. Cherbuy, C. et al. Microbiota matures colonic epithelium through a coordinated induction of cell cycle-related proteins in gnotobiotic rat. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G348-G357 (2010).
99. Hsu, D. et al. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab. Invest. 90, 1295-1305 (2010).
100. Brandl, K. et al. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc. Natl. Acad. Sci. USA 107, 19967-19972 (2010).
101. Lin, Y. et al. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275, 24255-24263 (2000).
102. Rehli, M. et al. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275, 9773-9781 (2000).
103. Suzuki, R., Kohno, H., Sugie, S. & Tanaka, T. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol. Histopathol. 20, 483-492 (2005).
104. Fukata, M. et al. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm. Bowel Dis. 15, 997-1006 (2009).
105. Lowe, E.L. et al. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS One 5, e13027 (2010).
106. Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103-113 (2009).
107. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022 (2009).
108. Fransen, F. et al. Differential effect of TLR2 and TLR4 on the immune response after immunization with avaccine against Neisseriameningitidis or Bordetella pertussis. PLoS One 5, e15692 (2010).
109. Salcedo, R. et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625-1636 (2010).
110. Uronis, J.M. et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 4, e6026 (2009).
111. Schiechl, G. et al. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+ CD11b(high)Gr1(low) macrophages. J. Clin. Invest. 121, 1692-1708 (2011).
112. Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124-127 (2007).
113. Watters, T.M., Kenny, E.F. & O'Neill, L.A. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 85, 411-419 (2007).
114. Hu, B. et al. Inflammation-induced tumorigenesis in the colon isregulated by caspase-1 and NLRC4.Proc. Natl. Acad. Sci. USA107, 21635-21640 (2010).
115. Allen, I.C. et al. NLRP12 suppresses colon inflammation and tumorigen-esis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 36, 742-754 (2012).
116. Zaki, M.H. et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20, 649-660 (2011).
117. Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. in press (2013).
118. Balkow, S. et al. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity. Exp. Dermatol. 18, 78-87 (2009).
119. Ey, B., Eyking, A., Gerken, G., Podolsky, D.K. & Cario, E. TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J. Biol. Chem. 284, 22332-22343 (2009).
120. Fort, M.M. et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J. Immunol. 174, 6416-6423 (2005).
121. Ungaro, R. et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1167-G1179 (2009).
122. Raja, S.G. & Dreyfus, G.D. Eritoran: the evidence of its therapeutic potential in sepsis. Core Evid. 2, 199-207 (2008).
123. Watanabe, T. et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118, 545-559 (2008).
124. Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 187, 61-70 (2009).
125. Kuipers, M.T. et al. Ventilator-induced lung injury is mediated by the NLRP3 inflammasome. Anesthesiology 116, 1104-1115 (2012).
126. Abreu, M.T., Fukata, M. & Arditi, M. TLR signaling in the gut in health and disease. J. Immunol. 174, 4453-4460 (2005).
127. Pott, J. et al. Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog. 8, e1002670 (2012).
128. Wells, J.M., Loonen, L.M. & Karczewski, J.M. The role of innate signaling in the homeostasis of tolerance and immunity in the intestine. Int. J. Med. Microbiol. 300, 41-48 (2010).
129. Kim, J.G., Lee, S.J. & Kagnoff, M.F. Nod1 is anessential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect. Immun. 72, 1487-1495 (2004).
130. Inohara, Chamaillard, McDonald, C. & Nunez, G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74, 355-383 (2005).
131. Hirata, Y., Broquet, A.H., Menchen, L. & Kagnoff, M.F. Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells. J. Immunol. 179, 5425-5432 (2007).
132. Volman, J.J., Mensink, R.P., Buurman, W.A., Onning, G. & Plat, J. The absence of functional dectin-1 on enterocytes may serve to prevent intestinal damage. Eur. J. Gastroenterol. Hepatol. 22, 88-94 (2010).
133. Martinon, F. & Tschopp, J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26, 447-454 (2005).
134. Ohtani, K. et al. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 276, 44222-44228 (2001).
135. Nguyen, D.G. & Hildreth, J.E. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33, 483-493 (2003).
136. van Asbeck, E.C., Hoepelman, A.I., Scharringa, J., Herpers, B.L. & Verhoef, J. Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol. 8, 229 (2008).
137. Teh, C., Le, Y., Lee, S.H. & Lu, J. M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 101, 225-232 (2000).
138. den Dunnen, J., Gringhuis, S.I. & Geijtenbeek, T.B. Innate signalingby the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol. Immunother. 58, 1149-1157 (2009).
139. Brown, G.D. et al. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197, 1119-1124 (2003).
140. Rachmilewitz, D. et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126, 520-528 (2004).
141. Vijay-Kumar, M. et al. Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm. Bowel Dis. 13, 856-864 (2007).
142. Vijay-Kumar, M. et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol. 180, 8280-8285 (2008).
143. Rachmilewitz, D.et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122, 1428-1441 (2002).
144. Obermeier, F. et al. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin. Exp. Immunol. 134, 217-224 (2003).